Tiziana Life Sciences (TLSA) Retained Earnings (2017 - 2025)

Tiziana Life Sciences has reported Retained Earnings for 9 years, with the latest figure at -$163.1 million in Q4 2025.

• On a quarterly basis, Retained Earnings fell 12.62% year-over-year to -$163.1 million in Q4 2025; TTM through Dec 2025 was -$163.1 million, a 12.62% decrease from a year earlier, with the FY2025 full-year figure at -$163.1 million, down 12.62% from the prior year.
• Retained Earnings was -$163.1 million for Q4 2025 at Tiziana Life Sciences, down from -$150.5 million in the prior quarter.
• The five-year high for Retained Earnings was -$101.7 million in Q2 2021, with the low at -$163.1 million in Q4 2025.
• Average Retained Earnings over 5 years is -$129.4 million, with a median of -$129.3 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2022: Retained Earnings plunged 73.0% in 2021, then declined 7.59% in 2022.
• Over 5 years, Retained Earnings stood at -$108.1 million in 2021, then dropped by 7.59% to -$116.3 million in 2022, then fell by 14.98% to -$133.7 million in 2023, then retreated by 8.34% to -$144.8 million in 2024, then fell by 12.62% to -$163.1 million in 2025.
• The last three Retained Earnings figures came in at -$163.1 million (Q4 2025), -$150.5 million (Q2 2025), and -$144.8 million (Q4 2024), per Business Quant data.